| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2012 | Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy | Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng | Hepatology | | | |
| 2014 | Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials | Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng | Hepatology | | | |
| 2021 | Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | YU-YUN SHAO ; Wang, Shen-Yung; Lin, Shi-Ming; Chen, Kuan-Yang; Tseng, Jeng-Hwei; MING-CHIH HO ; Lee, Rheun-Chuan; PO-CHIN LIANG ; Liao, Li-Ying; KAI-WEN HUANG ; Hu, Jui-Ting; JA-DER LIANG ; Kee, Kwong-Ming; Lin, Chih-Lin; Wang, Chung-Kwe; Lu, Sheng-Nan; Wang, Jing-Houng; Lee, Wei-Chen; CHIEN-HUNG CHEN ; CHUN-JEN LIU ; Huang, Yi-Hsiang; Wang, Chia-Chi; Wang, Tsang-En; Chuang, Po-Heng; Dai, Chia-Yen; CHIUN HSU ; Chen, San-Chi; Hsieh, Chia-Hsun | Journal of the Formosan Medical Association | 43 | 50 | |
| 2023 | Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan | Tsai, Pei-Chien; Kuo, Hsing-Tao; Hung, Chao-Hung; Tseng, Kuo-Chih; Lai, Hsueh-Chou; Peng, Cheng-Yuan; Wang, Jing-Houng; Chen, Jyh-Jou; Lee, Pei-Lun; Chien, Rong-Nan; Yang, Chi-Chieh; Lo, Gin-Ho; Kao, Jia-Horng; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan, Sheng-Lei; Bair, Ming-Jong; Lin, Chun-Yen; Su, Wei-Wen; Chu, Cheng-Hsin; Chen, Chih-Jen; Tung, Shui-Yi; Tai, Chi-Ming; Lin, Chih-Wen; Lo, Ching-Chu; Cheng, Pin-Nan; Chiu, Yen-Cheng; Wang, Chia-Chi; Cheng, Jin-Shiung; Tsai, Wei-Lun; Lin, Han-Chieh; Huang, Yi-Hsiang; Yeh, Ming-Lun; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Huang, Jee-Fu; Dai, Chia-Yen; Chung, Wan-Long; Chen, Chi-Yi; Yu, Ming-Lung | Journal of hepatology | 2 | 0 | |
| 2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
| 2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
| 2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 81 | 75 | |
